CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 591493-591637 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/ee0a7632371a08727d41e55aad7d621daeceef7d","sourcedb":"CORD-19","sourceid":"ee0a7632371a08727d41e55aad7d621daeceef7d","text":"Evaluation of patients with POLE mutated tumors in immunotherapy trials will further guide the best use of such testing for treatment decisions.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T69438","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T69438","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T113","span":{"begin":0,"end":144},"obj":"Sentence"}],"attributes":[{"subj":"T113","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2790","span":{"begin":41,"end":47},"obj":"Disease"},{"id":"T64157","span":{"begin":41,"end":47},"obj":"Disease"}],"attributes":[{"id":"A2790","pred":"mondo_id","subj":"T2790","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A53311","pred":"mondo_id","subj":"T64157","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"subj":"T2790","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T64157","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#939eec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#b8ec93"},{"id":"CORD-19-PD-MONDO","color":"#ec93d2"}]}]}}